-
Loading metrics
Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Taro Kishi,
- Yuki Matsuda,
- Nakao Iwata
x
- Published: February 4, 2014
- https://doi.org/10.1371/journal.pone.0088049